Q3 2020 Business Update amid Covid-19
Business performance: risk costs (abs/rel*) -
Risk cost development in line with guidance.
0
Group
AT/EBO e
60
Q3 19
Q2 20
Q3 20
Yoy higher risk costs due to releases in Q3 19 and Covid-19
related allocations in Q3 20
Qoq risk cost development driven by updated risk parameters
to reflect deteriorated macro outlook following Covid-19
induced crisis, mainly booked in Q2 20 and to a lesser extent
in Q3 20
Ytd risk costs at 70bps
Year-on-year segment trends:
Higher allocations across most geographies (except RS) in the
light of Covid-19
Quarter-on-quarter segment trends:
0.00%
614
195
☐ 1.48%
0.46%
0.04%
0.68%
0.17%
-0.03%
AT/SB
126
1.02%
25
0.20%
0
-0.01%
•
AT/OA
84
2.06%
42
1.00%
0.03%
CZ
112
1.54%
41
☐ 0.57%
-7
-0.33%
RO
80
22
9
10.27%
52
1.41%
23
☐ 0.61%
-3
-0.31%
.
HU
54
4.89%
0.86%
-5
-0.27%
HR
41
2.25%
22
1.18%
RS
06
0.09%
1.45%
-1
-0.23%
Other
40
Not meaningful
=
SK
H
-4
in EUR m
0.99%
3.60%
•
Continued assessment of forward-looking information and stage
overlays in Q3 20, together with effects of portfolio migrations.
Less significant allocations in Q3 due to stable macro outlook
since Q2 20
RS: Release of excess allowances
*) A positive (absolute) figure denotes risk costs, a negative figure denotes net releases.
Relative risk costs are calculated as annualised quarterly impairment result of financial
instruments over average gross customer loans.
ERSTEŚ
Group
Page 34View entire presentation